Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany. | Biolojic Design

Categories: News | Published On: June 3, 2024 | Written by webadmin@biolojic.com |

Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany.

More News

Biolojic Design Appoints Roger Waltzman as Chief Medical Officer
Read More
Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma
Read More

BUSINESS AND MEDIA INQUIRIES

Micah Pearlman
micah@biolojic.com